| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |